Last Updated: July 2026
The FDA and FTC divide regulatory responsibility over dietary supplements: the FDA primarily oversees product labeling, manufacturing standards, and safety, while the FTC oversees the truthfulness of advertising claims made in marketing materials, websites, and social media. A green tea extract supplement could have a fully compliant FDA label while still violating FTC rules if its advertising overstates weight-loss benefits beyond what evidence supports.
In December 2022, the FTC published updated Health Products Compliance Guidance, replacing its 1998 dietary supplement advertising guide. This document raised expectations around the quality of clinical evidence needed to support health claims, generally favoring randomized, placebo-controlled human clinical trials directly testing the finished product or a substantially similar formulation, rather than relying solely on general ingredient research or animal studies.
Systematic reviews aggregating multiple clinical trials provide the most reliable picture of green tea's weight-management effects. These reviews generally describe the observed effect size as small and the underlying evidence quality as inconsistent across studies, which directly limits how a compliant advertising claim can be worded.
"Green tea preparations appear to induce a small, statistically non-significant weight loss in overweight or obese adults, and the overall quality of evidence across included trials was assessed as low to moderate."
— Jurgens TM, et al., Cochrane Database of Systematic Reviews. View related Cochrane review
This evidence pattern means that broad, unqualified claims such as "burns fat fast" or "guaranteed weight loss" are unlikely to meet the FTC's substantiation standard, whereas more measured claims tied to specific study conditions may be defensible if properly documented.
| Claim Type | Example Phrasing Pattern | FTC Risk Level |
|---|---|---|
| Unqualified outcome claim | "Burns fat fast" / "Guaranteed weight loss" | High — unlikely to meet substantiation standard |
| General mechanism claim | "Supports metabolism" (structure/function claim) | Moderate — requires FDA structure/function disclaimer and underlying evidence |
| Study-qualified claim | "In a clinical study of this formulation, participants experienced modest changes when combined with diet and exercise" | Lower — tied directly to documented study conditions |
| # | Audit Item |
|---|---|
| 1 | Confirm any cited clinical study tested the actual finished formulation, not just the raw ingredient in isolation |
| 2 | Avoid absolute or guaranteed outcome language for weight loss |
| 3 | Include the required FDA structure/function claim disclaimer where applicable |
| 4 | Have marketing copy reviewed by qualified legal counsel before publication, particularly for the US market |
Q: Can I say "clinically proven to burn fat" if my ingredient supplier cites a study on EGCG?
A: Generally no — FTC guidance favors claims tied to studies on the actual finished formulation, not general ingredient-level research, so ingredient studies alone typically cannot support strong finished-product outcome claims.
Q: Does a "supports healthy metabolism" claim avoid FTC scrutiny entirely?
A: No, structure/function claims still require underlying substantiation and the standard FDA disclaimer; softer wording reduces but does not eliminate the need for supporting evidence.